Morning Briefing
Summaries of health policy coverage from major news organizations
2 New Studies Add To Evidence Of Risks With Diabetes Drug Avandia As FDA Prepares To Debate It's Safety
Questions about the drug's safety have been raised before and the controversy goes to the heart of FDA oversight.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
